- Drostanolone Enanthate 100 mg/ml
Drostanolone enanthate 100mg/ml – 250ml
25 gram Drostanolone enanthate (20ml)
5ml BA (2%)
50ml BB (20%)
Drostanolone enanthate is an ester of drostanolone. Drostanolone is
indicated in postmenopausal women with recurrent breast cancer, in
combined hormone therapy. Drostanolone causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and
decreases amino acid catabolism.
The antitumor activity of drostanolone appears related to reduction or
competitive inhibition of prolactin receptors or estrogen receptors or
Drostanolone enanthate 100 USP injection provides drostanolone
enanthate, a potent androgenic steroid that has similar characteristics
of dihydrotestosterone. Drostanolone is incapable of aromization and
therefore it doesn’t convert into oestrogen. Both drostanolone’s
anabolic and androgenic activity is far greater than methyl testosterone.The esterification of the 17-beta-hydroxyl group increases the duration of the action of drostanolone.
Drostanolone esters in oil injected intramuscularly are absorbed slowly
from the lipid phase, thus Drostanolone enanthate 100E can be
administered at intervals of every 1-2 weeks.
Drostanolone enanthate 100 contains drostanolone enanthate in a
10ml solution for injection (100mg drostanolone enanthate / ml).
Drostanolone enanthate 100 is a